China Medical GatewayLoading your healthcare gateway…

Zhang Yong

Zhang Yong — Chief Physician — Urology — Medical Academy Cancer Hospital

Specialties

Specializes in robotic and laparoscopic minimally invasive surgery and comprehensive treatment of urinary system tumors, including bladder cancer, kidney cancer, prostate cancer, ureteral cancer, testicular tumors, and adrenal tumors. Especially skilled in robot-assisted/fully laparoscopic radical cystectomy with ileal neobladder for bladder cancer, robot-assisted/fully laparoscopic radical cystectomy with orthotopic neobladder, etc. Also has extensive experience in robot-assisted/laparoscopic radical prostatectomy (nerve-sparing technique), robot-assisted/laparoscopic radical nephrectomy for kidney cancer, robot-assisted/laparoscopic partial nephrectomy (kidney-sparing surgery), robot-assisted/laparoscopic total nephroureterectomy, robot-assisted/laparoscopic nephron-sparing surgery for complex renal tumors, robot-assisted/laparoscopic radical nephrectomy with inferior vena cava tumor thrombus removal, and robot-assisted/laparoscopic resection of large retroperitoneal tumors.

Education

PhD in Urology, Hebei Medical University

Professional Experience

Deputy Director of the Department of Urology and Director of the Urology Department at the Langfang Hospital. Chief Physician, Professor, Doctor of Medicine, and PhD Supervisor. He has conducted academic visits at Malmö University Hospital of Lund University in Sweden, Cleveland Clinic in the United States, Johns Hopkins Hospital in the United States, and Keck Medical Center of the University of Southern California, systematically studying minimally invasive laparoscopic and robotic surgery for urinary tract tumors as well as comprehensive treatment of related tumors. He is skilled in the diagnosis and treatment of kidney cancer, bladder cancer, prostate cancer, adrenal tumors, urothelial carcinoma, and testicular tumors, and has completed over 4,000 urological laparoscopic surgeries.

Professional Roles

He serves as the Deputy Director-General of the Urology Branch of the Chinese Medical Doctor Association, a member and Deputy Secretary-General of the Minimally Invasive and Robotics Group of the Urology Branch of the Chinese Medical Doctor Association, a member of the Robotics Group of the Urology Branch of the Chinese Medical Association, the Deputy Chairman of the Urologic Oncology Committee of the Beijing Anti-Cancer Society, and a member of the Bladder Cancer Group of the Urology Branch of the Chinese Anti-Cancer Association.

Return to Home